Added to YB: 2025-09-05
Pitch date: 2025-09-03
PRTC.L [bullish]
PureTech Health plc
+5.53%
current return
Author Info
The Oak Bloke shares analysis of the UK stock market, particularly overlooked small caps. Sign up for the newsletter.
Company Info
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States.
Market Cap
GBP 374.8M
Pitch Price
GBP 1.16
Price Target
2.78 (+128%)
Dividend
N/A
EV/EBITDA
-1.62
P/E
7.70
EV/Sales
31.32
Sector
Biotechnology
Category
value
PRTC-e doesn't always make perfect - Puretech the OB Laggard Idea down 32%
PRTC.L: Biotech w/ proven success via $14bn Karuna sale, now trading at 1.1x book vs peers at 2.5-4.5x. £236m cash runway to 2028, net £44m EV. Seaport (35% owned) valued $597m, up from $325m. Two Phase 3 programs (Celea, Vedanta), Phase 2 Seaport, Phase 1b Gallop. £211m Cobenfy royalties est vs £500m+ potential. 278p target.
Read full article (13 min)